HIV Citation List: September 30 - October 13, 2009

Pubmed citations:

1. PRO 140 - A Novel CCR5 Co-Receptor Inhibitor. Khatib N, Das S. Recent Pat Antiinfect Drug Discov. 2009 Oct 7. [Epub ahead of print] PMID: 19807678

2. Purification and Characterization of a Laccase with Inhibitory Activity toward HIV-1 Reverse Transcriptase and Tumor Cells from an Edible Mushroom (Pleurotus cornucopiae). Wong JH, Ng TB, Jiang Y, Liu F, Cho S, Sze W, Zhang KY. Protein Pept Lett. 2009 Oct 7. [Epub ahead of print] PMID: 19807674

3. Chemical Library Screens Targeting an HIV-1 Accessory Factor/Host Cell Kinase Complex Identify Novel Anti-retroviral Compounds. Emert-Sedlak L, Kodama T, Lerner EC, Dai W, Foster C, Day B, Lazo JS, Smithgall TE. ACS Chem Biol. 2009 Oct 6. [Epub ahead of print] PMID: 19807124

4. A New Small Molecule Inhibitor Class Targeting HIV-1 Virion Maturation. Blair WS, Cao J, Fok-Seang J, Griffin P, Isaacson J, Jackson RL, Murray E, Patick AK, Peng Q, Perros M, Pickford C, Wu H, Butler SL. Antimicrob Agents Chemother. 2009 Oct 5. [Epub ahead of print] PMID: 19805571

5. Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents. Kuo RY, Qian K, Morris-Natschke SL, Lee KH. Nat Prod Rep. 2009 Oct;26(10):1321-1344. Epub 2009 Aug 13. PMID: 19779642

6. A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry. Baleux F, Loureiro-Morais L, Hersant Y, Clayette P, Arenzana-Seisdedos F, Bonnaffé D, Lortat-Jacob H. Nat Chem Biol. 2009 Oct;5(10):743-8. Epub 2009 Sep 6. PMID: 19734912

7. Pyrazole NNRTIs 3: optimisation of physicochemical properties. Mowbray CE, Corbau R, Hawes M, Jones LH, Mills JE, Perros M, Selby MD, Stupple PA, Webster R, Wood A. Bioorg Med Chem Lett. 2009 Oct 1;19(19):5603-6. Epub 2009 Aug 14. PMID: 19717303

8. Pyrazole NNRTIs 1: design and initial optimisation of a novel template. Mowbray CE, Burt C, Corbau R, Perros M, Tran I, Stupple PA, Webster R, Wood A. Bioorg Med Chem Lett. 2009 Oct 1;19(19):5599-602. Epub 2009 Aug 13. PMID: 19709880

9. Small molecule targets Env for endoplasmic reticulum-associated protein degradation and inhibits human immunodeficiency virus type 1 propagation. Jejcic A, Daniels R, Goobar-Larsson L, Hebert DN, Vahlne A. J Virol. 2009 Oct;83(19):10075-84. Epub 2009 Jul 29. PMID: 19640982

10. Design, expression, and characterization of a multivalent, combination HIV microbicide. Sexton A, Harman S, Shattock RJ, Ma JK. FASEB J. 2009 Oct;23(10):3590-600. Epub 2009 May 26. PMID: 19470798

ISI Web of Knowledge citations:

11. Synthesis and Anti-Human Immunodeficiency Virus Type 1 Activity of (E)-N-Phenylstyryl-N-alkylacetamide Derivatives. Cheng, P; Chen, JJ; Huang, N; Wang, RR; Zheng, YT; Liang, YZ. MOLECULES, 2009; 14(9): 3176-3186.

12. Structure-based design of substituted biphenyl ethylene ethers as ligands binding in the hydrophobic pocket of gp41 and blocking the helical bundle formation. Liu, B; Joseph, RW; Dorsey, BD; Schiksnis, RA; Northrop, K; Bukhtiyarova, M; Springman, EB. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009; 19(19): 5693-5697.

13. Synthesis and biological evaluation of new heterocyclic quinolinones as anti-parasite and anti-HIV drug candidates. Darque, A; Dumetre, A; Hutter, S; Casano, G; Robin, M; Pannecouque, C; Azas, N. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009; 19(20): 5962-5964.

14. Phosphodiester Substrates for Incorporation of Nucleotides in DNA Using HIV-1 Reverse Transcriptase. Giraut, A; Dyubankova, N; Song, XP; Herdewijn, P. CHEMBIOCHEM, 2009; 2246-2252.